Investors are excited about the potential for a settlement in opioid litigation.
News & Analysis: Endo International
It looks like a short-squeeze scenario is unfolding.
Earnings and other factors continued to provide a lift to some stocks.
The pharma company's legal settlement with two Ohio counties and its regulatory filing for a new drug pleased investors.
Concerns about a possible bankruptcy filing by another opioid maker are taking a big toll on Endo.
Despite some nervousness in the broader market, earnings and other good news helped boost these stocks.
Investors are cheering the drugmaker's settlement in principle of two lawsuits related to its opioid drugs.
Investors appear to have some confidence that the companies will settle their opioid lawsuits.
ENDP earnings call for the period ending June 30, 2019.
Shares fall even though the company posted better-than-expected results. What can explain the move?